Insider Trading History of Arch Venture Partners Viii, L.p.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Arch Venture Partners Viii, L.p. since 2020. This trader's CIK number is 1616176. At the time of last reporting, Arch Venture Partners Viii, L.p. was the 10% Owner of Codiak Biosciences, Inc.. (stock ticker symbol CDAK). Also see all insider trading activities at Codiak Biosciences, Inc..

Note that in the past ARCH Venture Partners VIII, L.P. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Codiak Biosciences, Inc. (CDAK) by Arch Venture Partners Viii, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 CDAK 5,000,000 $7,500,000 0 $0 0 $0
2020 CDAK 235,000 $3,525,000 0 $0 0 $0

Yearly summary of insider trading at Metacrine, Inc. (MTCR) by Arch Venture Partners Viii, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 MTCR 230,000 $2,990,000 0 $0 0 $0


Insider trading activities at 2 companies by Arch Venture Partners Viii, L.p.:

1. Codiak Biosciences, Inc. (CDAK)

2. Metacrine, Inc. (MTCR)

Table 1. Insider trading of Codiak Biosciences, Inc. (CDAK) by Arch Venture Partners Viii, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-09-13 CDAK Buy 5,000,000 1.50 7,500,000
2020-10-16 CDAK Buy 235,000 15.00 3,525,000

Table 2. Insider trading of Metacrine, Inc. (MTCR) by Arch Venture Partners Viii, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-09-18 MTCR Buy 230,000 13.00 2,990,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Arch Venture Partners Viii, L.p. (10% Owner of Codiak Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.